Table of Contents
<< Previous Issue | Jan 2023 (Vol: 2023, Issue: 1) | Next Issue >> |
- Section: Opinion & Analysis
-
Early Signs of M&A Activity Heating Up in 2023
- Section: Research & Development
-
Moderna Signs US$1.2 B Collaboration with Oncology Specialist CytomX
-
AbbVie Partners with Immunome and Anima in Oncology-Focused Deals